GCS
CLPT icon

Gordian Capital (Singapore)’s ClearPoint Neuro CLPT Stock Holding History

Gordian Capital (Singapore)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$41K – 138
2025
Q4 		$41K Sell
3,000
-4,300
-59% -$79.7K 0.06% 87
2025
Q3 		$159K Buy
+7,300
New +$86K 0.22% 69

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Gordian Capital (Singapore)'s CLPT Position: Q1 2026 in Review

Gordian Capital (Singapore) sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 3,000 shares — an estimated $41K sold.

Gordian Capital (Singapore) first reported a position in CLPT in Q3 2025 and held it in 2 quarters. The position peaked at $159K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Gordian Capital (Singapore) reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 3,000 ClearPoint Neuro shares in Q1 2026, an estimated $41K.
  • Gordian Capital (Singapore) first reported a position in ClearPoint Neuro in Q3 2025 and held it in 2 quarters.
  • Gordian Capital (Singapore)'s ClearPoint Neuro position peaked at $159K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.